![Teva Pharmaceuticals Recalls Acute Myeloid Leukemia Drug Over Particulate Matter Contamination - Top Class Actions Teva Pharmaceuticals Recalls Acute Myeloid Leukemia Drug Over Particulate Matter Contamination - Top Class Actions](https://s40123.pcdn.co/wp-content/uploads/2022/03/recallTeva-700x547.jpg)
Teva Pharmaceuticals Recalls Acute Myeloid Leukemia Drug Over Particulate Matter Contamination - Top Class Actions
![Teva completes $703M sale of women's health products to CVC Capital Partners. - Philadelphia Business Journal Teva completes $703M sale of women's health products to CVC Capital Partners. - Philadelphia Business Journal](https://media.bizj.us/view/img/10777492/47002105ovaleap300ie-0-5ml*750xx640-360-0-60.jpg)
Teva completes $703M sale of women's health products to CVC Capital Partners. - Philadelphia Business Journal
![Omeprazole Generic Drug Box by Teva Closeup Against White Editorial Photo - Image of cure, health: 185176486 Omeprazole Generic Drug Box by Teva Closeup Against White Editorial Photo - Image of cure, health: 185176486](https://thumbs.dreamstime.com/z/kyiv-ukraine-may-gastroenterology-generic-drug-omeprazole-teva-box-blisters-closeup-white-teva-pharmaceuticals-185176486.jpg)
Omeprazole Generic Drug Box by Teva Closeup Against White Editorial Photo - Image of cure, health: 185176486
![Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News](https://s.abcnews.com/images/US/teva-pharma-2-gty-ps-221103_1667481193658_hpMain_1x1_992.jpg)
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
![Teva Pharmaceuticals Announces Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America Teva Pharmaceuticals Announces Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America](https://community.aafa.org/fileSendAction/fcType/0/fcOid/510642830861510679/filePointer/510642830861510701/fodoid/510642830861510696/imageType/MEDIUM/inlineImage/true/Teva-announced-launch-of-new-daily-asthma-medicine.png)
Teva Pharmaceuticals Announces Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America
![ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business](https://mms.businesswire.com/media/20180914005613/en/678526/5/AJOVY+Image.jpg)